Solomon, S. D. Et Al. 2022. Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial. EUROPEAN HEART JOURNAL , vol.43, no.23 , 2212-2220.

Solomon, S. D., Claggett, B. L., Miao, Z. M., Diaz, R., Felker, G. M., McMurray, J. J., ... Metra, M.(2022). Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial. EUROPEAN HEART JOURNAL , vol.43, no.23, 2212-2220.

Solomon, Scott Et Al. "Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial," EUROPEAN HEART JOURNAL , vol.43, no.23, 2212-2220, 2022

Solomon, Scott D. Et Al. "Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial." EUROPEAN HEART JOURNAL , vol.43, no.23, pp.2212-2220, 2022

Solomon, S. D. Et Al. (2022) . "Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial." EUROPEAN HEART JOURNAL , vol.43, no.23, pp.2212-2220.

@article{article, author={Scott D. Solomon Et Al. }, title={Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial}, journal={EUROPEAN HEART JOURNAL}, year=2022, pages={2212-2220} }